📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Fusobacterium nucleatum, rectal cancer and radiotherapy (2020)

First Author: Mann E

Attributed to: Pathfinder: Defining interactions between the cytokine IL-22 and oncogenic KRAS as a new therapeutic target in colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2020.06.019

PubMed Identifier: 32629022

Publication URI: http://europepmc.org/abstract/MED/32629022

Type: Journal Article/Review

Parent Publication: Annals of Oncology

Issue: 10

ISSN: 0923-7534